'Not just a flavoring:' Menthol and nicotine, combined, desensitize airway receptors
2014-11-16
(Press-News.org) WASHINGTON -- Menthol acts in combination with nicotine to desensitize receptors in lungs' airways that are responsible for nicotine's irritation, say neuroscientists at Georgetown University Medical Center (GUMC).
"We know that a menthol cough drop soothes a scratchy, sore throat. The question we looked at is if and how it works when the irritant is nicotine," says a study author, Kenneth Kellar, PhD, a professor of pharmacology at GUMC.
The findings, which represent work by Georgetown University investigators in GUMC's Department of Pharmacology & Physiology, will be presented by Hoai Ton, PhD, a post-doctoral researcher, on Sunday, Nov. 16 at Neuroscience 2014, the Society for Neuroscience's annual meeting in Washington.
"This study supports the notion that menthol is not just a flavoring, but has a pharmacologic effect," Kellar says.
The U.S. Food and Drug Administration (FDA) is considering restrictions on menthol cigarettes because it has determined that menthol in cigarettes is likely associated with increased initiation and progression to regular cigarette smoking, increased dependence, and reduced success in smoking cessation, especially among African American menthol smokers. But FDA's review of the available research and evidence relating to menthol cigarettes, issued in July 2013, also concluded, "From the available studies, the weight of evidence supports the conclusion that menthol in cigarettes is not associated with an increase in disease risk to the user compared to non-menthol cigarette smokers."
At the same time, the use of menthol cigarettes is especially high among African-American smokers, and research has shown a higher rate of lung cancer in African American smokers compared to other smokers.
"The issue may be that menthol in the presence of nicotine may reduce the irritation enough that a smoker can inhale more deeply, bringing not just nicotine but toxic smoke products farther into the lungs," says co-investigator Gerald Ahern, PhD, an associate professor of pharmacology at GUMC. 'While beyond the scope of this study, it is possible that such deeper inhalation of menthol cigarettes, to the extent it occurs, increases the already substantial health harms from smoking."
The researchers say their study provides a better understanding of how menthol affects the function of the α3β4 receptor, one of the most prevalent nicotinic acetylcholine receptors expressed in the peripheral nervous system. These receptors are expressed in airway sensory nerves as well as other neurons.
"These receptors are also found in the brain, but we don't know yet what effect menthol has on those receptors, or whether they contribute, in any way, to nicotine addiction," Kellar says.
INFORMATION:
Study contributors also include research assistant Thao Olson. The research was funded by a National Institutes of Health grant (DA012976).
The authors report having no personal financial interests related to the study.
About Georgetown University Medical Center
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.
Follow us: Twitter @GUMedCenter and Facebook https://www.facebook.com/GUMCUpdate.
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-16
In 2013, University of North Carolina School of Medicine researchers published a study with a surprising finding: Patients who suffered an ST elevation myocardial infarction (STEMI) heart attack while in the hospital for something else are more likely to die than patients who had the same type of heart attack outside the hospital.
Today the UNC researchers published a new study, based on data from more than 62,000 patients treated at hundreds of hospitals in California, which confirms their earlier finding.
"This study is the largest ever performed on patients who ...
2014-11-16
Prashant Kaul, M.D., of the University of North Carolina, Chapel Hill, and colleagues conducted a study to define the incidence and treatment and outcomes of patients who experience a certain type of heart attack during hospitalization for conditions other than acute coronary syndromes. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
Early restoration of blood flow with percutaneous coronary intervention (PCI; a procedure such as stent placement used to open narrowed coronary arteries) or administration of medication to dissolve ...
2014-11-16
Matthew D. Ritchey, D.P.T., of the Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues examined the contributions of heart disease subtypes to overall heart disease mortality trends during 2000-2010. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
Despite considerable information on overall heart disease (HD) and coronary HD (CHD) mortality trends, less is known about trends for other HD subtypes. The researchers analyzed mortality data from the CDC WONDER database, which contains death certificate information ...
2014-11-16
Vivek Y. Reddy, M.D., of the Icahn School of Medicine at Mount Sinai, New York, and colleagues examined the long-term efficacy and safety, compared to warfarin, of a device to achieve left atrial appendage closure in patients with atrial fibrillation. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
The left atrial appendage (LAA) is a pouch-like appendix located in the upper left chamber of the heart. Studies have suggested that the LAA is the major source of clots that block blood vessels in patients with atrial fibrillation ...
2014-11-16
Lars H. Lund, M.D., Ph.D., of the Karolinska Institutet, Stockholm, Sweden, and colleagues conducted a study to examine whether beta-blockers are associated with reduced mortality in heart failure patients with preserved ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction).The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
Up to half of patients with heart failure have normal or near-normal ejection fraction, termed heart failure with preserved ejection fraction (HFPEF). The risk of ...
2014-11-16
Duk-Woo Park, M.D., of the University of Ulsan College of Medicine, Seoul, Korea, and Manesh R. Patel, M.D., of the Duke Clinical Research Institute, Durham, N.C., and colleagues investigated the incidence, extent, and location of obstructive non-infarct-related artery (IRA) disease and compared 30-day mortality according to the presence of non-IRA disease in patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack). Obstructive non-IRA disease is blockage in arteries not believed to be the cause ...
2014-11-16
Stefanie Schulz-Schupke, M.D., of the Deutsches Herzzentrum Munchen, Technische Universitat, Munich, Germany and colleagues assessed whether vascular closure devices are noninferior (not worse than) to manual compression in terms of access site-related vascular complications in patients undergoing diagnostic coronary angiography. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
Percutaneous (through the skin) coronary angiography and interventions have become a cornerstone in the diagnosis and treatment of coronary artery disease. ...
2014-11-16
Giulio Conte, M.D., of the Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium and colleagues investigated the clinical significance of repeat testing after puberty in asymptomatic children with a family history of Brugada syndrome who had an initial negative test earlier in childhood. Brugada syndrome is a genetic disease that is characterized by abnormal electrocardiogram findings without structural heart disease and an increased risk of sudden cardiac death. The study appears in the November 19 issue of JAMA, a cardiovascular disease theme issue.
Brugada ...
2014-11-16
DURHAM, N.C. - A blocked artery causes a deadly kind of heart attack known as STEMI, and a rapid response to clear the blockage saves lives.
But in more than half of cases studied recently by Duke Medicine researchers, one or both of the patient's other arteries were also obstructed, raising questions about whether and when additional procedures might be undertaken.
In a study published in the Nov. 19, 2014, issue of the Journal of the American Medical Association, Duke researchers and their colleagues report the first large analysis of how often these secondary blockages ...
2014-11-16
A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks well-established treatment. HFPEF involves an impaired ability of the heart to fill with blood, and affects nearly 2% of the population. These new findings are being published in the scientific periodical JAMA.
Heart failure was for a long time defined as reduced ability to contract the heart and pump oxygenated blood out to the rest of the body. This condition is often ...
LAST 30 PRESS RELEASES:
[Press-News.org] 'Not just a flavoring:' Menthol and nicotine, combined, desensitize airway receptors